Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
Article in Journal of Molecular Medicine (February 2024)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
EphA2 proteolytic fragment as a sensitive diagnostic biomarker for very early-stage pancreatic ductal carcinoma
Article in Cancer Research Communications (September 2023)
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation
Article in Nature Communications (May 2021)